Publications
Filters: Author is Aranda, E [Clear All Filters]
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British journal of cancer. 2010;103(4):581-9. Abstract
Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. European journal of cancer (Oxford, England : 1990). 2008;44(9):1229-37. Abstract
